PIRELLI UK LIMITED

Company number 00133461 ·

Active

This analysis was written by an AI from the company's public filings. It may contain errors or omissions and is not financial or professional advice.

Financial Health Assessment: PIRELLI UK LIMITED

Applying a rigorous diagnostic methodology to the corporate filings of Pirelli UK Limited, I have evaluated this 110-year-old entity to determine its underlying financial wellness. Because the available financial data is limited to balance sheet share capital and corporate structure (typical for a head office entity), this assessment focuses heavily on structural vitals, compliance health, and ownership DNA.

1. Financial Health Score: B+ (Provisional)

Explanation: The patient exhibits an excellent structural and compliance heartbeat, with no symptoms of administrative distress. However, the score is provisional rather than definitive because the current "blood work" (detailed profit & loss and full balance sheet metrics) is not present in this specific filing extract. The high score is heavily supported by the immense "parental" immune system provided by its ultimate owners, Pirelli & C. S.p.A and China National Chemical Corporation.

2. Key Vital Signs

  • Compliance Pulse: Strong & Steady. The company’s accounts are made up to December 2024 and are not overdue, nor is the confirmation statement overdue. This indicates a healthy, well-regulated corporate heartbeat with no arrhythmias in its statutory duties.
  • Corporate Longevity: Excellent Genetic Resilience. Incorporated in 1914, the company has survived over a century of economic cycles, rebranding, and structural changes (transitioning from Cable Works to a PLC, and finally to a Limited company). This indicates deep institutional resilience.
  • Capital Circulation: Unusually Lean. The share capital stands at a mere £232. While this might look like a case of severe financial anemia, it is actually a normal symptom for a company operating under SIC code 7010 (Activities of head offices). Head office entities often require minimal issued share capital, relying instead on continuous "transfusions" of inter-company funding from their parent organizations.
  • Ownership DNA: Dominant Parental Genes. The company is wholly controlled by two global giants—Pirelli & C. S.p.A and China National Chemical Corporation (ChemChina). They hold over 75% of shares, voting rights, and director appointment powers. This provides an incredibly strong safety net, though it leaves the patient entirely dependent on the systemic health of its parents.

3. Diagnosis

Diagnosis: Structurally Sound, Dependent Subsidiary

Pirelli UK Limited is the UK central nervous system (head office) for a much larger global organism. The financial data reveals no lesions or symptoms of distress—no overdue filings, no liquidation status, and a stable board of international executives.

The extremely low share capital of £232 is not a symptom of a starving business; rather, it is the anatomical signature of a holding company. Such entities typically operate with minimal equity and rely on massive inter-company receivables and payables to fund operations. The patient is entirely tethered to the circulatory system of its Italian and Chinese parent companies. Consequently, its own standalone vitals look artificially weak, but its actual ability to survive a shock is incredibly high due to the parental guarantee implicit in the ownership structure.

4. Recommendations

To maintain and improve financial wellness, the following preventative care measures are advised: * Monitor the Parent's Systemic Health: Because Pirelli UK Limited is wholly dependent on its parent companies for its financial "transfusions," any circulatory failure at the Pirelli S.p.A or ChemChina level will immediately threaten this entity. Regularly monitor the consolidated financial statements of the parent companies to anticipate any reduction in inter-company support. * Maintain Compliance Hygiene: The company has a flawless compliance record. It is critical to maintain this hygiene to avoid regulatory infections (fines or penalties) that could trigger unwanted attention from creditors or regulators. * Review Inter-company Balances: Ensure that the "transfusions" (inter-company loans and receivables) are properly documented, legally enforceable, and reviewed annually. If the parent companies ever face liquidity crises, having properly secured inter-company debts will ensure Pirelli UK Limited is treated as a priority creditor rather than a subordinated dependent.

Perspective: Financial Health Diagnostician · Model: glm-5.1 · Generated 4 August 2026